Unite de Fabrication de Medicaments SA stock price and financial data
Invest with RicherFin and research the stock. Unite de Fabrication de Medicaments SA (UMED), BVMT : share price and history, results and fundamentals, analysis tools and peer companies.
An investment account is required to buy shares. Demo mode uses virtual money: no order is sent to the market.
Price history
Issuer profile
Unite de Fabrication de Medicaments SA is a Tunisia-based company principally engaged in the pharmaceutical sector. The Company has labaroatories where it develops production in two main areas: Generic Drugs, where it concentrates on the production and marketing of drugs under its own brand of Unimed, and Shaped Drugs, which are the drugs manufactured for third party laboratories customers.
Fundamentals
connect to view moreSign in to unlock the full fundamentals history.
Sign in| Metric (TND, M) | 2025 2025 | 2024 2024 | 2023 2023 | 2022 2022 | 2021 2021 |
|---|---|---|---|---|---|
| Revenue Total Revenue | 160 | ||||
| EBITDA | 59 | ||||
| EBIT | 40.9 | ||||
| Net income Net Income | 23.6 | ||||
| Net margin | 14.75% |